Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Khaled R Alkharsah

13PUBLICATIONS

17CO-AUTHORS

Medical virologyInfant and child healthMedical infection agents (incl. prions)Preventative health careCross-sectional analysis

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (13)

Sort by Publication Date:

|Mar 26, 2025

Modulatory Effects of the Recombinant Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Spike S1 Subunit Protein on the Phenotype of Camel Monocyte-Derived Macrophages.

Jamal Hussen, Abdullah I A Al-Mubarak, Turke Shawaf

|Nov 11, 2022

The Scope of Respiratory Syncytial Virus Infection in a Tertiary Hospital in the Eastern Province of Saudi Arabia and the Change in Seasonal Pattern during and after the COVID-19 Pandemic.

Khaled R Alkharsah

|Apr 12, 2022

Low levels of soluble DPP4 among Saudis may have constituted a risk factor for MERS endemicity.

Khaled R Alkharsah, Salma Ali Aljaroodi, Jawad Ur Rahman

|Apr 11, 2022

Susceptibility to Rubella Infection and Incidence of Congenital Rubella Infection: 6 Years Retrospective Study.

Reem A Al Dossary, Sarah Althuwaiqeb, Khaled R Alkharsah

|Jan 27, 2022

The Appropriateness to Use Fixed Assay Cut-Offs for Estimating Seroprevalence [Response to Letter].

Khaled R Alkharsah, Adel I Al-Afaleq

|Jan 07, 2022

Serological Evidence of West Nile Virus Infection Among Humans, Horses, and Pigeons in Saudi Arabia.

Khaled R Alkharsah, Adel I Al-Afaleq

Pageof 3

Frequent Collaborators

3 joint publications

Reem Al Dossary

2 joint publications

Haitham Kussaibi

2 joint publications

Salma Ali Aljaroodi

2 joint publications

Jawad Ur Rahman

2 joint publications

Amani M Alnimr

2 joint publications

Jamal Hussen

1 joint publications

Maha Abdel Hadi

1 joint publications

Mohammed S Alshahrani

1 joint publications

Peter Naniima

1 joint publications

Benjamin Vollmer

Frequent Collaborators

3 joint publications

Reem Al Dossary

2 joint publications

Haitham Kussaibi

2 joint publications

Salma Ali Aljaroodi

2 joint publications

Jawad Ur Rahman

Top Related Videos

Polarization of M1 and M2 Human Monocyte-Derived Cells and Analysis with Flow Cytometry upon <em>Mycobacterium tuberculosis</em> Infection

Polarization of M1 and M2 Human Monocyte-Derived Cells and Analysis with Flow Cytometry upon <em>Mycobacterium tuberculosis</em> Infection

Published on : Sep 18, 2020

Development of Multiplex Real-Time RT-qPCR Assays for the Detection of SARS-CoV-2, Influenza A/B, and MERS-CoV

Development of Multiplex Real-Time RT-qPCR Assays for the Detection of SARS-CoV-2, Influenza A/B, and MERS-CoV

Published on : Nov 10, 2023

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on : Mar 01, 2019

See more related videos

Top Related Videos

Polarization of M1 and M2 Human Monocyte-Derived Cells and Analysis with Flow Cytometry upon <em>Mycobacterium tuberculosis</em> Infection

Polarization of M1 and M2 Human Monocyte-Derived Cells and Analysis with Flow Cytometry upon <em>Mycobacterium tuberculosis</em> Infection

Published on : Sep 18, 2020

Development of Multiplex Real-Time RT-qPCR Assays for the Detection of SARS-CoV-2, Influenza A/B, and MERS-CoV

Development of Multiplex Real-Time RT-qPCR Assays for the Detection of SARS-CoV-2, Influenza A/B, and MERS-CoV

Published on : Nov 10, 2023

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on : Mar 01, 2019

See more related videos